Immunic
IMUX
54 hedge funds and large institutions have $115M invested in Immunic in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 17 closing their positions.
387% more capital invested
Capital invested by funds: $23.7M → $115M (+$91.6M)
205% more call options, than puts
Call options by funds: $7.79M | Put options by funds: $2.55M
111% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 9
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
4% less funds holding
Funds holding: 56 → 54 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.8M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
+$4.47M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4M |
| 4 |
SRF
Silver Rock Financial
Los Angeles,
California
|
+$1.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
-$432K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$317K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$196K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$193K |
| 5 |
PG
PEAK6 Group
Chicago,
Illinois
|
-$166K |
IMUX Hedge Fund Activity: Q4 2015 in Review
54 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q4 2015, worth a combined $115M — up 387% from $23.7M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of IMUX and 16 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 19 added.
The largest buyer was Fidelity Investments, adding an estimated $14.8M. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $432K sold.
- 54 institutional investors held Immunic (IMUX) as of Q4 2015, down from 56 in Q3 2015.
- Funds reported $115M of Immunic stock for Q4 2015, up 387% quarter-over-quarter.
- 16 funds opened new Immunic positions in Q4 2015 and 17 closed out, a net change of -1 holder.
- The largest Immunic buyer in Q4 2015 was Fidelity Investments, an estimated $14.8M added.
- The largest Immunic seller in Q4 2015 was A.R.T. Advisors, an estimated $432K sold.
Based on aggregated 13F filings for Q4 2015.